Niche-to-niche migration of bone-marrow-derived cells

Schofield, 1978, The relationship between the spleen colony-forming cell and the haemopoietic stem cell, Blood Cells, 4, 7 Adams, 2006, The hematopoietic stem cell in its place, Nat. Immunol., 7, 333, 10.1038/ni1331 Palis, 1999, Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse, Development, 126, 5073, 10.1242/dev.126.22.5073 Cumano, 2001, Intraembryonic, but not yolk sac hematopoietic precursors, isolated before circulation, provide long-term multilineage reconstitution, Immunity, 15, 477, 10.1016/S1074-7613(01)00190-X de Bruijn, 2000, Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo, EMBO J., 19, 2465, 10.1093/emboj/19.11.2465 Medvinsky, 1998, Development of the definitive hematopoietic hierarchy in the mouse, Dev. Comp. Immunol., 22, 289, 10.1016/S0145-305X(98)00007-X Bollerot, 2005, The embryonic origins of hematopoietic stem cells: a tale of hemangioblast and hemogenic endothelium, APMIS, 113, 790, 10.1111/j.1600-0463.2005.apm_317.x Huber, 2004, Haemangioblast commitment is initiated in the primitive streak of the mouse embryo, Nature, 432, 625, 10.1038/nature03122 Mendes, 2005, Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny, Development, 132, 1127, 10.1242/dev.01615 Takahashi, 1999, Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization, Nat. Med., 5, 434, 10.1038/8462 Isner, 2001, Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repair, Ann. N. Y. Acad. Sci., 953, 75, 10.1111/j.1749-6632.2001.tb02075.x LaRue, 2003, Circulating blood island-derived cells contribute to vasculogenesis in the embryo proper, Dev. Biol., 262, 162, 10.1016/S0012-1606(03)00358-0 Pardanaud, 2006, Identification, emergence and mobilization of circulating endothelial cells or progenitors in the embryo, Development, 133, 2527, 10.1242/dev.02421 Kiel, 2005, SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells, Cell, 121, 1109, 10.1016/j.cell.2005.05.026 Lord, 1975, The relative spatial distributions of CFUs and CFUc in the normal mouse femur, Blood, 46, 65, 10.1182/blood.V46.1.65.65 Nilsson, 2001, Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches, Blood, 97, 2293, 10.1182/blood.V97.8.2293 Wilson, 2006, Bone-marrow haematopoietic-stem-cell niches, Nat. Rev. Immunol., 6, 93, 10.1038/nri1779 Taichman, 1998, The role of osteoblasts in the hematopoietic microenvironment, Stem Cells, 16, 7, 10.1002/stem.160007 Balduino, 2005, Bone marrow subendosteal microenvironment harbours functionally distinct haemosupportive stromal cell populations, Cell Tissue Res., 319, 255, 10.1007/s00441-004-1006-3 Visnjic, 2004, Hematopoiesis is severely altered in mice with an induced osteoblast deficiency, Blood, 103, 3258, 10.1182/blood-2003-11-4011 Calvi, 2003, Osteoblastic cells regulate the haematopoietic stem cell niche, Nature, 425, 841, 10.1038/nature02040 Stier, 2002, Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome, Blood, 99, 2369, 10.1182/blood.V99.7.2369 Nilsson, 2005, Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells, Blood, 106, 1232, 10.1182/blood-2004-11-4422 Stier, 2005, Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size, J. Exp. Med., 201, 1781, 10.1084/jem.20041992 Li, 2003, Primary endothelial cells isolated from the yolk sac and para-aortic splanchnopleura support the expansion of adult marrow stem cells in vitro, Blood, 102, 4345, 10.1182/blood-2003-03-0729 Kopp, 2005, The bone marrow vascular niche: home of HSC differentiation and mobilization, Physiology (Bethesda), 20, 349, 10.1152/physiol.00025.2005 Avecilla, 2004, Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis, Nat. Med., 10, 64, 10.1038/nm973 Nervi, 2006, Cytokines and hematopoietic stem cell mobilization, J. Cell. Biochem., 99, 690, 10.1002/jcb.21043 Pilarski, 1999, Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells, Blood, 93, 2918, 10.1182/blood.V93.9.2918 Yin, 2006, The stem cell niches in bone, J. Clin. Invest., 116, 1195, 10.1172/JCI28568 Heissig, 2002, Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand, Cell, 109, 625, 10.1016/S0092-8674(02)00754-7 Kopp, 2006, Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue, Curr. Opin. Hematol., 13, 175, 10.1097/01.moh.0000219664.26528.da Kollet, 2006, Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells, Nat. Med., 12, 657, 10.1038/nm1417 Petit, 2002, G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4, Nat. Immunol., 3, 687, 10.1038/ni813 Peled, 1999, Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4, Science, 283, 845, 10.1126/science.283.5403.845 Nagasawa, 1996, Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1, Nature, 382, 635, 10.1038/382635a0 Ara, 2003, Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny, Immunity, 19, 257, 10.1016/S1074-7613(03)00201-2 Dar, 2005, Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells, Nat. Immunol., 6, 1038, 10.1038/ni1251 Adams, 2006, Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor, Nature, 439, 599, 10.1038/nature04247 Wright, 2001, Physiological migration of hematopoietic stem and progenitor cells, Science, 294, 1933, 10.1126/science.1064081 Abkowitz, 2003, Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure, Blood, 102, 1249, 10.1182/blood-2003-01-0318 de Sousa, 1976, Cell traffic, 105 Kaplan, 2005, VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche, Nature, 438, 820, 10.1038/nature04186 Grunewald, 2006, VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells, Cell, 124, 175, 10.1016/j.cell.2005.10.036 Massberg, 2006, Platelets secrete stromal cell-derived factor 1a and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo, J. Exp. Med., 203, 1211, 10.1084/jem.20051772 Jin, 2006, Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes, Nat. Med., 12, 557, 10.1038/nm1400 Orimo, 2005, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion, Cell, 121, 335, 10.1016/j.cell.2005.02.034 Salven, 2003, VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells, Blood, 101, 168, 10.1182/blood-2002-03-0755 Ceradini, 2004, Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1, Nat. Med., 10, 858, 10.1038/nm1075 Okuyama, 2006, Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1, J. Biol. Chem., 281, 15554, 10.1074/jbc.M602003200 Pola, 2003, Postnatal recapitulation of embryonic hedgehog pathway in response to skeletal muscle ischemia, Circulation, 108, 479, 10.1161/01.CIR.0000080338.60981.FA Li, 2006, VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization, FASEB J., 20, 1495, 10.1096/fj.05-5137fje Lyden, 1999, Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts, Nature, 401, 670, 10.1038/44334 Lyden, 2001, Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth, Nat. Med., 7, 1194, 10.1038/nm1101-1194 Studeny, 2004, Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents, J. Natl. Cancer Inst., 96, 1593, 10.1093/jnci/djh299 Papayannopoulou, 2001, Molecular pathways in bone marrow homing: dominant role of a4b1 over b2-integrins and selectins, Blood, 98, 2403, 10.1182/blood.V98.8.2403 Jin, 2006, A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature, J. Clin. Invest., 116, 652, 10.1172/JCI24751 Peters, 2005, Contribution of bone marrow-derived endothelial cells to human tumor vasculature, Nat. Med., 11, 261, 10.1038/nm1200 Ruzinova, 2003, Effect of angiogenesis inhibition by Id loss and the contribution of bone marrow-derived endothelial cells in spontaneous murine tumours, Cancer Cell, 4, 277, 10.1016/S1535-6108(03)00240-X Scadden, 2006, The stem-cell niche as an entity of action, Nature, 441, 1075, 10.1038/nature04957 Li, 2006, Normal stem cells and cancer stem cells: the niche matters, Cancer Res., 66, 4553, 10.1158/0008-5472.CAN-05-3986 Rafii, 2003, Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration, Nat. Med., 9, 702, 10.1038/nm0603-702 Laflamme, 2005, Regenerating the heart, Nat. Biotechnol., 23, 845, 10.1038/nbt1117 Assmus, 2006, Transcoronary transplantation of progenitor cells after myocardial infarction, N. Engl. J. Med., 355, 1222, 10.1056/NEJMoa051779 Schachinger, 2006, Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction, N. Engl. J. Med., 355, 1210, 10.1056/NEJMoa060186 Rosenzweig, 2006, Cardiac cell therapy – mixed results from mixed cells, N. Engl. J. Med., 355, 1274, 10.1056/NEJMe068172 Ripa, 2006, Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease, Eur. Heart J., 27, 1785, 10.1093/eurheartj/ehl117 Donovan, 2000, Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization, Development, 127, 4531, 10.1242/dev.127.21.4531 Rafii, 2002, Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy, Nat. Rev. Cancer, 2, 826, 10.1038/nrc925 Herbrig, 2006, Endothelial progenitor cells in chronic renal insufficiency, Kidney Blood Press. Res., 29, 24, 10.1159/000092484 Walter, 2005, Impaired CXCR4 signalling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease, Circ. Res., 97, 1142, 10.1161/01.RES.0000193596.94936.2c Murakami, 2006, Signalling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages, Blood, 108, 1849, 10.1182/blood-2006-04-016030 Woodhouse, 1997, General mechanisms of metastasis, Cancer, 80, 1529, 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F Yang, 2006, Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells, Cancer Res., 66, 46, 10.1158/0008-5472.CAN-05-3086 Christofori, 2006, New signals from the invasive front, Nature, 441, 444, 10.1038/nature04872 Balkwill, 2004, The significance of cancer cell expression of the chemokine receptor CXCR4, Semin. Cancer Biol., 14, 171, 10.1016/j.semcancer.2003.10.003 Kalluri, 2006, Fibroblasts in cancer, Nat. Rev. Cancer, 6, 392, 10.1038/nrc1877 Muller, 2001, Involvement of chemokine receptors in breast cancer metastasis, Nature, 410, 50, 10.1038/35065016 Wai, 2004, The role of osteopontin in tumor metastasis, J. Surg. Res., 121, 228, 10.1016/j.jss.2004.03.028 Hiratsuka, 2002, MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis, Cancer Cell, 2, 289, 10.1016/S1535-6108(02)00153-8 Semenza, 2003, Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer, 3, 721, 10.1038/nrc1187 Wu, 2006, The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma, Int. J. Cancer, 119, 1519, 10.1002/ijc.21865 Fernando, 2003, Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer, Semin. Oncol., 30, 39, 10.1016/S0093-7754(03)70024-4 Hurwitz, 2004, Bevacizumab plus irinotecan, fluorouacil, and leucovorin for metastatic colorectal cancer, N. Engl. J. Med., 350, 2334, 10.1056/NEJMoa032691 Jubb, 2006, Predicting benefit from anti-angiogenic agents in malignancy, Nat. Rev. Cancer, 6, 626, 10.1038/nrc1946 Casanovas, 2005, Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors, Cancer Cell, 8, 299, 10.1016/j.ccr.2005.09.005 Miller, 2005, Can tumor angiogenesis be inhibited without resistance?, EXS, 94, 95 Fidler, 1999, Critical determinants of cancer metastasis: rationale for therapy, Cancer Chemother. Pharmacol., 43, S3, 10.1007/s002800051091 Lum, 2006, The new face of bispecific antibodies: targeting cancer and much more, Exp. Hematol., 34, 1, 10.1016/j.exphem.2005.07.013 De Palma, 2003, Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells, Nat. Med., 9, 789, 10.1038/nm871 Arafat, 2000, Genetically modified CD24+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells, Clin. Cancer Res., 6, 4442 Komarova, 2006, Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses, Mol. Cancer Ther., 5, 755, 10.1158/1535-7163.MCT-05-0334 Lotem, 2006, Epigenetics and the plasticity of differentiation in normal and cancer stem cells, Oncogene, 25, 7663, 10.1038/sj.onc.1209816 Kalluri, 2006, Fibroblasts in cancer, Nature, 6, 392 Wai, 2004, The role of osteopontin in tumour metastasis, J. Surg. Res., 121, 228, 10.1016/j.jss.2004.03.028 Jin, 2006, A homing mechanism for bone marrow derived progenitor cell recruitment to the neovasculature, J. Clin. Invest., 116, 652, 10.1172/JCI24751 Christofori, 2006, New signals from the invasive front, Nature, 441, 444, 10.1038/nature04872 Hiratsuka, 2002, MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis, Cancer Cell, 2, 289, 10.1016/S1535-6108(02)00153-8 Usui, 2004, VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2, Inv. Ophth. Vis. Sci., 45, 368, 10.1167/iovs.03-0106 Ratajczak, 1998, Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor in regulating human haemopoietic cell growth, Br. J. Haem., 103, 969, 10.1046/j.1365-2141.1998.01076.x Bao, 2006, Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor, Cancer Res., 66, 7843, 10.1158/0008-5472.CAN-06-1010